Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1982-12-09
1985-06-11
Marantz, Sidney
Drug, bio-affecting and body treating compositions
Lymphokine
435235, A61K 3912, C12N 700
Patent
active
045228108
ABSTRACT:
Feline calicivirus FCV-2280 is used in a live, attenuated or killed form as a vaccine, either by itself or in combination with another feline calicivirus strain. The virus may be administered in an effective dosage in a variety of ways.
The virus FCV-2280 has been deposited at the A.T.C.C. on Dec. 9, 1982, and given accession No. VR 2057.
REFERENCES:
patent: 3937812 (1976-02-01), Bittle et al.
patent: 3944469 (1976-03-01), Bittle et al.
patent: 4264587 (1981-04-01), Pederson et al.
Burki et al., Infect. Immun., 14(4), 1976, 876-881.
Gaskell, C. J. et al., Res. Vet. Sci., (England), Jan. 1982, 32(1), pp. 23-26.
Foley Shawn P.
Marantz Sidney
Rowland Bertram I.
The Regents of the University of California
LandOfFree
Feline calicivirus vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Feline calicivirus vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Feline calicivirus vaccine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1182486